International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia

NCT02449044 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremia

Interventions

DRUG: Tolvaptan

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.